[HTML][HTML] A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease

…, H Emanuelsson, J Marco, V Legrand… - … England Journal of …, 1994 - Mass Medical Soc
Background Balloon-expandable coronary-artery stents were developed to prevent coronary
restenosis after coronary angioplasty. These devices hold coronary vessels open at sites …

Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European …

…, K Kervinen, G Laufer, V Legrand… - European heart …, 2010 - academic.oup.com
Some surveys have shown that the intended users are sometimes unaware of the existence
of guidelines, or simply do not translate them into practice. Thus, implementation …

Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries

…, V Legrand… - European heart …, 2010 - academic.oup.com
Aims Patient access to reperfusion therapy and the use of primary percutaneous coronary
intervention (p-PCI) or thrombolysis (TL) varies considerably between European countries. …

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

PW Serruys, B van Hout, H Bonnier, V Legrand… - The Lancet, 1998 - thelancet.com
Background The multicentre, randomised Benestent-II study investigated a strategy of
implantation of a heparincoated Palmar-Schatz stent plus antiplatelet drugs compared with the …

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the full anticoagulation …

ME Bertrand, V Legrand, J Boland, E Fleck, J Bonnier… - Circulation, 1998 - Am Heart Assoc
Background—Dual therapy with ticlopidine and aspirin has been shown to be as effective
as or more effective than conventional anticoagulation in patients with an optimal result after …

Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial

…, P Albertsson, R Erbel, V Legrand… - European heart …, 2015 - academic.oup.com
Aims Stenting an angiographically intermediate but functionally non-significant stenosis is
controversial. Nevertheless, it has been questioned if deferral of a functionally non-significant …

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the …

…, C Grothusen, D Dudek, G Heyrich, P Kolh, V LeGrand… - The Lancet, 2019 - thelancet.com
Background The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was
a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-…

Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified …

…, M Banovic, B Beleslin, M Vrolix, V Legrand… - Journal of the American …, 2013 - jacc.org
Objectives : This study sought to evaluate the feasibility and safety of autologous bone
marrow–derived and cardiogenically oriented mesenchymal stem cell therapy and to probe for …

Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial …

…, MA Costa, M Centemero, AS Abizaid, VMG Legrand… - Circulation, 2001 - Am Heart Assoc
Background Our aims were to compare coronary artery bypass grafting (CABG) and stenting
for the treatment of diabetic patients with multivessel coronary disease enrolled in the …

Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study

…, W Rutsch, G Heyndrickx, H Suryapranata, V Legrand… - Circulation, 1996 - Am Heart Assoc
Background The purpose of the Benestent-II Pilot Study was to evaluate the safety of
delaying and eliminating anticoagulant therapy in patients receiving a heparin-coated stent in …